Early Phase 1 Multiple Sclerosis Trial, Recruiting NCT07660601 Sponsor: Rutgers, The State University of New Jersey Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Early Phase 1 Multiple Sclerosis Trial, Recruiting

NCT07660601
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old
  • People who have a confirmed diagnosis of multiple sclerosis (MS)
  • People who are able to look at a computer screen and follow instructions in English, assessed by a short memory and thinking test where a score above 24 out of 30 is required
  • People who are right-handed, as measured by a standard handedness questionnaire
  • People who report having normal vision, or vision that is corrected to normal (for example, with glasses or contact lenses)

Who may not be able to join:

  • People with a psychiatric condition that requires medication, as those medications may affect brain activity results
  • People with a neurological condition other than MS that could affect thinking, balance, or physical health — such as a brain injury or stroke
  • People with a bone, joint, or muscle and nerve disorder that may affect balance or the ability to move around
  • People who are currently taking part in another thinking (cognitive) or physical training program during the study period
  • People who have had a relapse (new or returning MS symptoms) or have received steroid treatment in the 30 days before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Soha Saleh, PhD, Rutgers University

Phone: 9739720472

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Rutgers, The State University of New Jersey
Registry
ClinicalTrials.gov
Start date
31 January 2025
Est. completion
20 May 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

walking speed; Dynamic Gait Index (DGI); Resting-state brain connectivity; brain-muscle coherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov